ArticleScientific reports2026
A cross-sectional study of the burden and risk factors of impetigo and scabies among children during conflict in the middle area of the Gaza strip.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Impetigo and scabies, highly contagious skin infections, proliferate in the overcrowded and unhygienic conditions exacerbated by conflict. This cross-sectional study analyzed the demographic, environmental, and WaSH-related determinants of these infections among children in the middle area of the Gaza strip during its humanitarian crisis. The study was conducted between July and November 2024. Participants were recruited through a mixed non-probability sampling strategy combining systematic screening in displacement shelters and consecutive recruitment from red crescent dermatology clinics. Diagnoses of impetigo and scabies were clinically confirmed by a dermatologist following WHO case definitions for mass emergencies. Data were analyzed using univariate and multivariate logistic regression models to estimate crude and adjusted odds ratios (aOR) with 95% confidence intervals (CI). A total of 409 respondents were included in the study; 356 (87%) were diagnosed with impetigo and 150 (36.7%) with scabies, including 99 (24.2%) with co-infection. The majority of participants were from Deir Al-Balah (81%) and reported that they had been displaced at least once since the start of the conflict (91%). Most respondents lived in overcrowded areas (76%) and reported a sleeping-space occupancy exceeding ten individuals (61%). Compared with children aged 0–4 years (reference group), the odds of impetigo were significantly lower among those aged 5–9 years (aOR = 0.30, 95% CI 0.11–0.76, p = 0.013), 10–14 years (aOR = 0.31, 95% CI 0.11–0.82, p = 0.024), and 15–18 years (aOR = 0.11, 95% CI 0.04–0.37, p < 0.001). For scabies, adolescents aged 15–18 years had markedly higher odds compared with the 0–4 year group (aOR = 5.67, 95% CI 2.50–13.31, p < 0.001). Limited access to clean water significantly increased the odds of impetigo (aOR = 2.63, 95% CI 1.12–6.25, p = 0.028), and using public bathrooms independently increased the risk of scabies (aOR = 2.26, 95% CI 1.23–4.29, p = 0.010). The findings highlight an urgent need for coordinated hygiene interventions focused on restoring clean-water access, providing soap and disinfection supplies, and reducing shelter overcrowding. Rapid, targeted treatment and education for high-risk age groups, alongside improved sanitation management in shared facilities, are essential to interrupt transmission. Strengthening disease surveillance and repairing damaged health and water infrastructure should be prioritized to prevent recurrent outbreaks and reduce severe complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.